Literature DB >> 30012702

Permanently Farnesylated Prelamin A, Progeria, and Atherosclerosis.

Howard J Worman1, Susan Michaelis2.   

Abstract

Entities:  

Keywords:  Editorials; atherosclerosis; lamin; progeria

Mesh：

Substances：

Year:  2018        PMID： 30012702      PMCID： PMC6056017          DOI： 10.1161/CIRCULATIONAHA.118.034480

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Lamin a truncation in Hutchinson-Gilford progeria.

Authors:  Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Pierre Cau; Claire Navarro; Jeanne Amiel; Irène Boccaccio; Stanislas Lyonnet; Colin L Stewart; Arnold Munnich; Martine Le Merrer; Nicolas Lévy
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging.

Authors:  Cassandra D Ragnauth; Derek T Warren; Yiwen Liu; Rosamund McNair; Tamara Tajsic; Nichola Figg; Rukshana Shroff; Jeremy Skepper; Catherine M Shanahan
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

Review 3.  Laminopathies and the long strange trip from basic cell biology to therapy.

Authors:  Howard J Worman; Loren G Fong; Antoine Muchir; Stephen G Young
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

4.  Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity.

Authors:  Jemima Barrowman; Patricia A Wiley; Sarah E Hudon-Miller; Christine A Hrycyna; Susan Michaelis
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

5.  Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.

Authors:  Alberto M Pendás; Zhongjun Zhou; Juan Cadiñanos; José M P Freije; Jianming Wang; Kjell Hultenby; Aurora Astudillo; Annika Wernerson; Francisco Rodríguez; Karl Tryggvason; Carlos López-Otín
Journal:  Nat Genet       Date:  2002-04-01       Impact factor: 38.330

6.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

7.  A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Margarita Meta; Xin Qiao; David Frost; Joy Bauch; Catherine Coffinier; Sharmila Majumdar; Martin O Bergo; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

8.  A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.

Authors:  Loren G Fong; David Frost; Margarita Meta; Xin Qiao; Shao H Yang; Catherine Coffinier; Stephen G Young
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

9.  Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.

Authors:  Renee Varga; Maria Eriksson; Michael R Erdos; Michelle Olive; Ingrid Harten; Frank Kolodgie; Brian C Capell; Jun Cheng; Dina Faddah; Stacie Perkins; Hedwig Avallone; Hong San; Xuan Qu; Santhi Ganesh; Leslie B Gordon; Renu Virmani; Thomas N Wight; Elizabeth G Nabel; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 10.  Mouse models of atherosclerosis.

Authors:  J L Breslow
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728
View more
  8 in total

Review 1.  A humanized yeast system to analyze cleavage of prelamin A by ZMPSTE24.

Authors:  Eric D Spear; Rebecca F Alford; Tim D Babatz; Kaitlin M Wood; Otto W Mossberg; Kamsi Odinammadu; Khurts Shilagardi; Jeffrey J Gray; Susan Michaelis
Journal:  Methods       Date:  2019-01-06       Impact factor: 3.608

Review 2.  Intermediate filaments as effectors of differentiation.

Authors:  Catherine J Redmond; Pierre A Coulombe
Journal:  Curr Opin Cell Biol       Date:  2020-11-24       Impact factor: 8.382

3.  Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells.

Authors:  Guillaume Bidault; Marie Garcia; Jacqueline Capeau; Romain Morichon; Corinne Vigouroux; Véronique Béréziat
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

Review 4.  Hutchinson-Gilford Progeria Syndrome-Current Status and Prospects for Gene Therapy Treatment.

Authors:  Katarzyna Piekarowicz; Magdalena Machowska; Volha Dzianisava; Ryszard Rzepecki
Journal:  Cells       Date:  2019-01-25       Impact factor: 6.600

5.  Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice.

Authors:  Yuexia Wang; Khurts Shilagardi; Trunee Hsu; Kamsi O Odinammadu; Takamitsu Maruyama; Wei Wu; Chyuan-Sheng Lin; Christopher B Damoci; Eric D Spear; Ji-Yeon Shin; Wei Hsu; Susan Michaelis; Howard J Worman
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

Review 6.  Breaking the aging epigenetic barrier.

Authors:  Sweta Sikder; Ganesan Arunkumar; Daniël P Melters; Yamini Dalal
Journal:  Front Cell Dev Biol       Date:  2022-07-28

7.  Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome.

Authors:  Paul H Kim; Natalie Y Chen; Patrick J Heizer; Yiping Tu; Thomas A Weston; Jared L-C Fong; Navjot Kaur Gill; Amy C Rowat; Stephen G Young; Loren G Fong
Journal:  JCI Insight       Date:  2021-08-23

Review 8.  A Multisensory Network Drives Nuclear Mechanoadaptation.

Authors:  Asier Echarri
Journal:  Biomolecules       Date:  2022-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.